Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug-Induced Cardiomyopathy”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Not applicableNot Yet RecruitingNCT05377320
What this trial is testing

PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study

Who this might be right for
Heart FailureCoronary Artery DiseasePeripheral Artery Disease+5 more
Medical College of Wisconsin 60
Not applicableStudy completedNCT03166813
What this trial is testing

Remote Ischaemic Preconditioning in Childhood Cancer

Who this might be right for
Cardiotoxicity
The University of Hong Kong 68
Post-approval studies (Phase 4)Study completedNCT02053974
What this trial is testing

Spironolactone Against Anthracycline-induced Cardiomyopathy

Who this might be right for
Anthracycline Induced Cardiotoxicity
TC Erciyes University 90
Not applicableUnknownNCT03155802
What this trial is testing

Novel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines

Who this might be right for
CardiotoxicityHeart FailureBreast Cancer+3 more
Stony Brook University 35
Not applicableEnded earlyNCT05699915
What this trial is testing

Extensive CArdioVAscular Characterization and Follow-up of Patients Receiving Immune Checkpoint Inhibitors

Who this might be right for
CancerImmune-related Adverse EventCardiac Abnormalities, Variable+4 more
Algemeen Ziekenhuis Maria Middelares 105
Large-scale testing (Phase 3)UnknownNCT05792293
What this trial is testing

Role of Statin Therapy in Prevention of Anthracycline-Induced Cardiotoxicity

Who this might be right for
Doxorubicin Induced Cardiomyopathy
Ain Shams University 100
Not applicableUnknownNCT02571894
What this trial is testing

The Cardio-Oncology Breast Cancer Study

Who this might be right for
CardiotoxicityCardiomyopathiesBreast Cancer
Karolinska University Hospital 320
Not applicableUnknownNCT05921279
What this trial is testing

Understanding CARdiac Events in Breast Cancer

Who this might be right for
Breast CancerCardiotoxicityCardiomyopathies+3 more
National University of Ireland, Galway, Ireland 100
Not applicableUnknownNCT05584163
What this trial is testing

Pilot Study to Evaluate the Prevention and Safety of Doxorubicin-induced Cardiomyopathy Using Extracorporeal Shock Waves

Who this might be right for
Breast Cancer
Ewha Womans University Mokdong Hospital 72
Not applicableStudy completedNCT03510689
What this trial is testing

Genetics and Heart Health After Cancer Therapy

Who this might be right for
Breast CancerHereditary Breast/Ovarian Cancer (brca1, Brca2)Heart Diseases+1 more
Abramson Cancer Center at Penn Medicine 79
Not applicableEnded earlyNCT05781672
What this trial is testing

Prediction of Delayed Toxic Cardiomyopathy in Children

Who this might be right for
CardiotoxicityChildhood Cancer
University Hospital, Montpellier 134
Not applicableLooking for participantsNCT07633587
What this trial is testing

ATROPOS: Survival Analysis of ICI-associated Myocarditis

Who this might be right for
Immune Checkpoint Inhibitor-associated Myocarditis
Groupe Hospitalier Pitie-Salpetriere 1,500
Not applicableStudy completedNCT03855982
What this trial is testing

Monitoring Drug-induced Myocarditis (CardiTOX)

Who this might be right for
MyocarditisMyocardial FailureMyocardial Dysfunction
Groupe Hospitalier Pitie-Salpetriere 6,000
Not applicableUnknownNCT06309862
What this trial is testing

Immune Checkpoint Inhibitor Therapy for Cancer and Risk of Myocarditis or Cardiomyopathy

Who this might be right for
Cardio-OncologyCardiomyopathy Due to Drug
Sunnybrook Health Sciences Centre 15
Not applicableStudy completedNCT07041827
What this trial is testing

Cardiotoxicity and Other Late Effects After Radiotherapy and Immuno-chemoTherapy in Non-Hodgkin lYmphoma

Who this might be right for
Non Hodgkin LymphomaDLBCLCardiovascular Diseases+6 more
The Netherlands Cancer Institute 217
Early research (Phase 1)Study completedNCT04023110
What this trial is testing

Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab

Who this might be right for
CardiotoxicityRisk Factor, CardiovascularToxicity Due to Chemotherapy+3 more
Abramson Cancer Center at Penn Medicine 68
Not applicableLooking for participantsNCT06699056
What this trial is testing

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

Who this might be right for
Ventricular Ejection FractionLVFLV Dysfunction+12 more
Peerbridge Health, Inc 2,000
Not applicableUnknownNCT04461223
What this trial is testing

Evaluation of Myocardial Injury After Anthracycline Chemotherapy in Osteosarcoma Patients Using CMR

Who this might be right for
CardiotoxicityOsteosarcomaMyocardial Injury+2 more
Second Affiliated Hospital, Zhejiang University, School of Medicine 55
Not applicableLooking for participantsNCT04294771
What this trial is testing

JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors

Who this might be right for
MyocarditisCardiomyopathiesHeart Diseases+3 more
Groupe Hospitalier Pitie-Salpetriere 500,000
Not applicableStudy completedNCT04586894
What this trial is testing

Adverse Myocardial and Vascular Side Effects of Immune Checkpoint Inhibitors

Who this might be right for
CancerImmune DefectCardiovascular Abnormalities
Assistance Publique - Hôpitaux de Paris 50
Next Page